FOXO Technologies Announces Acquisition Agreement

An update from FOXO Technologies ( (FOXO) ) is now available.

On August 6, 2025, FOXO Technologies announced a non-binding agreement to acquire an assisted living and memory care facility in South Florida for $22 million. This move aligns with FOXO’s strategy to expand its healthcare services, potentially adding over 350 units for assisted living and memory care. The company is also nearing a definitive agreement for the acquisition of Vector Biosource, Inc., and continues to explore opportunities in the assisted living and behavioral health sectors, indicating a strategic expansion in its operations.

Spark’s Take on FOXO Stock

According to Spark, TipRanks’ AI Analyst, FOXO is a Underperform.

FOXO Technologies receives a low overall stock score primarily due to significant financial challenges, including continuous net losses, high debt, and negative cash flows. The technical analysis also suggests bearish momentum. Although valuation metrics are poor, recent corporate actions, such as acquisitions and restructuring, provide some hope for future improvement. However, these are not sufficient to outweigh the current financial and operational challenges facing the company.

To see Spark’s full report on FOXO stock, click here.

More about FOXO Technologies

FOXO Technologies Inc. operates in the healthcare and biotechnology sectors, owning subsidiaries such as Rennova Community Health, Myrtle Recovery Centers, and FOXO Labs. The company focuses on providing healthcare services, including hospital and behavioral health services, and developing biotechnology solutions to improve human health and lifespan.

Average Trading Volume: 2,642,078

Technical Sentiment Signal: Sell

Current Market Cap: $1.47M

For an in-depth examination of FOXO stock, go to TipRanks’ Overview page.